1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
24.87 -0.24 (-0.96%)
676.7K
XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Genmab - ADR - GMAB - stock price prediction, stock price target, analyst ratings from 9 analysts

Genmab - ADR has a share price target of US$ 31, revenue growth forecast of 22.3%, and profit growth estimate of -0.7% for FY25, based on top 9 analyst calls.